Pancreatic Cancer and FOLFIRINOX: Should We Resect All Responders?

Cristina R. Ferrone, Giovanni Marchegiani, Theodore S. Hong, David P. Ryan, Vikram Deshpande, Erin I. McDonnell, Francesco Sabbatino, Daniela Dias Santos, Jill N. Allen, Lawrence S. Blaszkowsky, Jeffrey W. Clark, Jason E. Faris, Lipika Goyal, Eunice L. Kwak, Janet E. Murphy, David T. Ting, Jennifer Y. Wo, Andrew X. Zhu, Andrew L. Warshaw, Keith D. Lillemoe, Carlos Fernández-del Castillo, Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer Annals of Surgery. ,vol. 261, pp. 12- 17 ,(2015) , 10.1097/SLA.0000000000000867

Margaret A. Tempero, Mokenge P. Malafa, Stephen W. Behrman, Al B. Benson, Ephraim S. Casper, E. Gabriela Chiorean, Vincent Chung, Steven J. Cohen, Brian Czito, Anitra Engebretson, Mary Feng, William G. Hawkins, Joseph Herman, John P. Hoffman, Andrew Ko, Srinadh Komanduri, Albert Koong, Andrew M. Lowy, Wen Wee Ma, Nipun B. Merchant, Sean J. Mulvihill, Peter Muscarella, Eric K. Nakakura, Jorge Obando, Martha B. Pitman, Sushanth Reddy, Aaron R. Sasson, Sarah P. Thayer, Colin D. Weekes, Robert A. Wolff, Brian M. Wolpin, Jennifer L. Burns, Deborah A. Freedman-Cass, Pancreatic Adenocarcinoma, Version 2.2014 Journal of The National Comprehensive Cancer Network. ,vol. 12, pp. 1083- 1093 ,(2014) , 10.6004/JNCCN.2014.0106

Maximilian Bockhorn, Faik G. Uzunoglu, Mustapha Adham, Clem Imrie, Miroslav Milicevic, Aken A. Sandberg, Horacio J. Asbun, Claudio Bassi, Markus Büchler, Richard M. Charnley, Kevin Conlon, Laureano Fernandez Cruz, Christos Dervenis, Abe Fingerhutt, Helmut Friess, Dirk J. Gouma, Werner Hartwig, Keith D. Lillemoe, Marco Montorsi, John P. Neoptolemos, Shailesh V. Shrikhande, Kyoichi Takaori, William Traverso, Yogesh K. Vashist, Charles Vollmer, Charles J. Yeo, Jakob R. Izbicki, Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. ,vol. 155, pp. 977- 988 ,(2014) , 10.1016/J.SURG.2014.02.001

Fausto Petrelli, Andrea Coinu, Karen Borgonovo, Mary Cabiddu, Mara Ghilardi, Veronica Lonati, Enrico Aitini, Sandro Barni, FOLFIRINOX-based neoadjuvant therapy in borderline resectable or unresectable pancreatic cancer: a meta-analytical review of published studies. Pancreas. ,vol. 44, pp. 515- 521 ,(2015) , 10.1097/MPA.0000000000000314

Mustafa Suker, Berend R Beumer, Eran Sadot, Lysiane Marthey, Jason E Faris, Eric A Mellon, Bassel F El-Rayes, Andrea Wang-Gillam, Jill Lacy, Peter J Hosein, Sing Yu Moorcraft, Thierry Conroy, Florian Hohla, Peter Allen, Julien Taieb, Theodore S Hong, Ravi Shridhar, Ian Chau, Casper H van Eijck, Bas Groot Koerkamp, FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis Lancet Oncology. ,vol. 17, pp. 801- 810 ,(2016) , 10.1016/S1470-2045(16)00172-8

Pascal Hammel, Florence Huguet, Jean-Luc van Laethem, David Goldstein, Bengt Glimelius, Pascal Artru, Ivan Borbath, Olivier Bouché, Jenny Shannon, Thierry André, Laurent Mineur, Benoist Chibaudel, Franck Bonnetain, Christophe Louvet, Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib the LAP07 randomized clinical trial JAMA. ,vol. 315, pp. 1844- 1853 ,(2016) , 10.1001/JAMA.2016.4324

Deborah Schrag, Optimizing Treatment for Locally Advanced Pancreas Cancer: Progress but No Precision. JAMA. ,vol. 315, pp. 1837- 1838 ,(2016) , 10.1001/JAMA.2016.4284

Thilo Hackert, Milena Sachsenmaier, Ulf Hinz, Lutz Schneider, Christoph W. Michalski, Christoph Springfeld, Oliver Strobel, Dirk Jäger, Alexis Ulrich, Markus W. Büchler, Locally Advanced Pancreatic Cancer: Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients. Annals of Surgery. ,vol. 264, pp. 457- 463 ,(2016) , 10.1097/SLA.0000000000001850